Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Apremilast did not work for treating severe alopecia areata.

Turpentine ointment is effective and safe for treating folliculitis.

Adherence to finasteride treatment for prostate issues is generally low.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Finasteride and dutasteride both increase chromogranin A levels similarly.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Finasteride 5mg/day improves hair loss in normoandrogenic Asian women.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Setipiprant did not significantly improve hair growth in men with hair loss.

Tislelizumab can cause cutaneous lupus erythematosus.

Upadacitinib may cause hair loss.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.